Neurology Medical News about Antiepileptic Drugs

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Extended-Release Formulations of Antiepileptic Drugs: Rationale and Comparative Value
Epilepsy Currents, 10/30/09

Perucca E – Extended–release products are designed to prolong the absorption of drugs with short half–lives, thereby allowing longer dosing intervals while minimizing fluctuations in serum drug levels. Differences in bioavailability may exist between extended–release and immediate–release formulations and among different brands of extended–release products. Therefore, when switching from one formulation to another, careful monitoring of clinical response and attention to the need for dose adjustment are warranted.

<< Previous
Vestibular Neuritis

Next >>
Disseminated cerebral tuberculosis in an immunocompetent...

Bone Density of Ambulatory Adult Patients Receiving Long-term Anticonvulsant Drug Therapy
Archives of Iranian Medicine, 11/11/09 Relevance Score: 66%

Antiepileptic Drug Use, Falls, Fractures and BMD in Postmenopausal Women: Findings from the Womens Health Initiative (WHI)
Journal of Bone and Mineral Research, 10/28/09 Relevance Score: 66%

Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2)
Acta Neurologica Scandinavica, 10/16/09 Relevance Score: 66%

Treatment For Epilepsy Is Possible Culprit For Development Of Schizophrenia
ScienceDaily, 10/26/09 Relevance Score: 65%

Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy
Neuropsychiatric Disease and Treatment, 10/20/09 Relevance Score: 64%